Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiarrhythmics Versus Implantable Defibrillators (AVID)
NCT00000531Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Sep 1992
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of amiodarone and sotalol in ventricular fibrillation (VF) and ventricular tachycardia (VT) (2 arms), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: Total Mortality at 3 years. Started Sep 1992; status: completed.
02
Drugs
amiodaronesotalol
03
Conditions
ventricular fibrillation (VF)ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT00000531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000531.